Gilead Sciences to buy Kite Pharma for $11.9bn

Biopharmaceutical company Gilead Sciences has entered a definitive agreement to acquire US-based Kite Pharma for approximately $11.9bn.

Source: Pharmaceutical Technology - August 28, 2017 Category: Pharmaceuticals Source Type: news